Skip to content

CancerIndexthe global index of cancer

Cancers Data Trials Drugs Genes Biomarkers Approvals Rankings Research gap Graph

Cancers Data Trials Drugs Genes Biomarkers Approvals Rankings Research gap Graph

Pulse Data updates Year in cancer Taxonomy Countries Compare Trial intelligence Trial map Drug pipeline Sources Methodology About Trust & policies Data downloads Developers (API)

Loading cancer entity…

CancerIndex

CancerIndex is a research and information platform. It is not a physician, does not diagnose, and does not recommend treatment. Population statistics do not predict individual outcomes.

Every number links to its source and retrieval date. Derived metrics carry a formula version. AI-generated synthesis is not enabled in this phase; all content is database-grounded.

About Trust & policies Data explorer Data downloads Pulse Data update log Developers (API)Sources Methodology Taxonomy Countries Compare Contact · contact@spboucher.ai Status

© 2026 CancerIndex · built and maintained by Simon-Pierre Boucher · contact contact@spboucher.ai · hosted on MacLustr (www.maclustr.io). Source data remains under the license of each provider — see /sources.

Bone Marrow Neoplasm — Research · CancerIndex

Cancers
Neoplasm
Neoplasm by Site
Hematopoietic and Lymphatic System Neoplasm
Bone Marrow Neoplasm

Cancer Family

Bone Marrow Neoplasm

CI-CAN-00000093Explore in graph →

Non-malignant1,035 active trials28 approved drugs633 evidence items

NCIt: C35370
MeSH: D019046

Overview
Statistics
Survival
Genomics18
Variants & evidence633
Drugs53
Trials4615
Research
Rankings
Sources & provenance

Research activity

PubMed record counts

Each count is the number of PubMed records returned by the exact query shown, at the time it was run. Counts are research-activity signals, not quality measures.

Data not yet available

No PubMed query has been run for this entity. Counts require a MeSH-anchored query built from the entity's terminology mappings; the query string is stored with each count so it can be reproduced.

What CancerIndex knows

Trials tab
Methodology: publication counts

Literature

Linked publications (219)

Publications linked to this entity or its descendants, newest first, 25 per page. Link method and validation status are shown; 'candidate' links have not been reviewed.

pubmedProvenance

Source: PubMed (NLM)
Dataset: PubMed E-utilities
Retrieved: Sep 8, 2026
Layer: normalized (units and labels harmonized; values unchanged)

PublishedShowing 126–150 of 219 publications · bibliographic data as recorded by PubMed; abstracts are not reproduced.

Correlation of mutation profile and response in patients with myelofibrosis treated with ruxolitinib.
· Blood · 2015 · PMID 26124496 · validated civic_curation pubmed
RUNX1 mutations in acute myeloid leukemia are associated with distinct clinico-pathologic and genetic features.
· Leukemia · 2016 · PMID 27137476 · validated civic_curation pubmed
DNMT3A mutations and response to the hypomethylating agent decitabine in acute myeloid leukemia.
· Leukemia · 2012 · PMID 22124213 · validated civic_curation pubmed
Safety and efficacy of bosutinib (SKI-606) in chronic phase Philadelphia chromosome-positive chronic myeloid leukemia patients with resistance or intolerance to imatinib.
· Blood · 2011 · PMID 21865346 · validated civic_curation pubmed
Impact of baseline BCR-ABL mutations on response to nilotinib in patients with chronic myeloid leukemia in chronic phase.
· J Clin Oncol · 2009 · PMID 19652056 · validated civic_curation pubmed
Bosutinib is active in chronic phase chronic myeloid leukemia after imatinib and dasatinib and/or nilotinib therapy failure.
· Blood · 2012 · PMID 22371878 · validated civic_curation pubmed
Association of an inversion of chromosome 16 with abnormal marrow eosinophils in acute myelomonocytic leukemia. A unique cytogenetic-clinicopathological association.
· N Engl J Med · 1983 · PMID 6577285 · validated

Showing 126–150 of 219 publications

← Previous
1
…
5
6
7
8
9
Next →

civic_curation

Identification of breakpoints in t(8;21) acute myelogenous leukemia and isolation of a fusion transcript, AML1/ETO, with similarity to Drosophila segmentation gene, runt.

· Blood · 1992 · PMID 1391946 · validated civic_curation pubmed

Distinctive immunophenotypic features of t(8;21)(q22;q22) acute myeloblastic leukemia in children.

· Blood · 1992 · PMID 1467524 · validated civic_curation pubmed

Morphological subtyping of acute myeloid leukemia with maturation (AML-M2): homogeneous pink-colored cytoplasm of mature neutrophils is most characteristic of AML-M2 with t(8;21).

· Leukemia · 1997 · PMID 9180287 · validated civic_curation pubmed

A novel specific signature of pediatric MOZ-CBP acute myeloid leukemia.

· Leuk Res · 2010 · PMID 20630590 · validated civic_curation pubmed

3q26.2/MECOM Rearrangements by Pericentric Inv(3): Diagnostic Challenges and Clinicopathologic Features.

· Cancers (Basel) · 2023 · PMID 36672407 · validated civic_curation pubmed

Complex chromosomal rearrangements leading to MECOM overexpression are recurrent in myeloid malignancies with various 3q abnormalities.

· Genes Chromosomes Cancer · 2016 · PMID 26815134 · validated civic_curation pubmed

Atypical 3q26/MECOM rearrangements genocopy inv(3)/t(3;3) in acute myeloid leukemia.

· Blood · 2020 · PMID 32219447 · validated civic_curation pubmed

Prognostic relevance of integrated genetic profiling in acute myeloid leukemia.

· N Engl J Med · 2012 · PMID 22417203 · validated civic_curation pubmed

Valproic acid in combination with all-trans retinoic acid and intensive therapy for acute myeloid leukemia in older patients.

· Blood · 2014 · PMID 24797300 · validated civic_curation pubmed

Minimal residual disease levels assessed by NPM1 mutation-specific RQ-PCR provide important prognostic information in AML.

· Blood · 2009 · PMID 19587375 · validated civic_curation pubmed

Wilms tumor 1 gene mutations are associated with a higher risk of recurrence in young adults with acute myeloid leukemia: a study from the Acute Leukemia French Association.

· Cancer · 2009 · PMID 19536888 · validated civic_curation pubmed

Molecular alterations of the IDH1 gene in AML: a Children's Oncology Group and Southwest Oncology Group study.

· Leukemia · 2010 · PMID 20376086 · validated civic_curation pubmed

Impact of IDH1 R132 mutations and an IDH1 single nucleotide polymorphism in cytogenetically normal acute myeloid leukemia: SNP rs11554137 is an adverse prognostic factor.

· J Clin Oncol · 2010 · PMID 20368538 · validated civic_curation pubmed

Potential application of IDH1 and IDH2 mutations as prognostic indicators in non-promyelocytic acute myeloid leukemia: a meta-analysis.

· Leuk Lymphoma · 2012 · PMID 22616558 · validated civic_curation pubmed

IDH1 and IDH2 mutation analysis in Chinese patients with acute myeloid leukemia and myelodysplastic syndrome.

· Ann Hematol · 2012 · PMID 21997850 · validated civic_curation pubmed

U2AF1 mutations in Chinese patients with acute myeloid leukemia and myelodysplastic syndrome.

· PLoS One · 2012 · PMID 23029227 · validated civic_curation pubmed

Phase II study of the oral MEK inhibitor selumetinib in advanced acute myelogenous leukemia: a University of Chicago phase II consortium trial.

· Clin Cancer Res · 2014 · PMID 24178622 · validated civic_curation pubmed

IDH1 inhibitor shows promising early results.

· Cancer Discov · 2015 · PMID 25583779 · validated civic_curation pubmed